Catatan efek · kuartal yang diarsipkan
AKRO
Akero Therapeutics, Inc. · Healthcare · Biotechnology
12Pemegang yang dilacak
+3Δ pemegang
18.33MSaham yang dipegang
$510.05MNilai yang dilaporkan
+3Posisi baru
−0Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang +30.0% ·
aliran saham +5.7% ·
posisi baru bersih +20.0%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2025 | 18 | 0 | 30.14M | $1.43B | +1 | −1 |
| Q2 2025 | 15 | -1 | 29.65M | $1.58B | — | −1 |
| Q1 2025 | 13 | +1 | 19.73M | $798.59M | +1 | — |
| Q4 2024 | 12 | +3 | 18.33M | $510.05M | +3 | — |
| Q3 2024 | 8 | 0 | 15.01M | $430.62M | +1 | −1 |
| Q2 2024 | 8 | — | 11.90M | $279.29M | — | — |
Siapa yang memegangnya · Q4 2024
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 4.32M | +13.5% | $120.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 4.32M | +13.5% | $120.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (pasif) | 2.34M | — | $64.99M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasif) | 1.56M | -0.7% | $43.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasif) | 1.56M | -0.7% | $43.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.35M | +803.9% | $37.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.35M | +803.9% | $37.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 899.68K | -31.0% | $25.03M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 275.07K | Baru | $7.65M | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 275.07K | Baru | $7.65M | 0.0% | New | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 127.32K | +43.4% | $3.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 35.81K | -69.2% | $996,206 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 20.80K | Baru | $578,656 | 0.0% | New | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 16.74K | -77.6% | $465,596 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 8.65K | Baru | $240,698 | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 8.65K | Baru | $240,698 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $7.65M | 0.0% |
| Marshall Wace | $7.65M | 0.0% |
| Renaissance Technologies | $578,656 | 0.0% |
| AQR Capital Management | $240,698 | 0.0% |
| AQR Capital Management | $240,698 | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q4 2024 ·
Metodologi ·
Dapatkan ini melalui API